Strides Pharma Science Ltd. benchmarking: Perfomance to industry peers

Financial

	Strides Pharma Scien	Marksans Pharma	Sanofi India
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	230.0 .	25.0 .	n/a
Number of ANDA's Approved By USFDA	215.0 .	13.0 .	n/a
R&D as a % of Total Sales	1.84 %	2.0 %	0.0
Financials
5 yr Average ROE	23.7 %	17.57 %	52.02 %
5yr average Equity Multiplier	2.62	1.33	4.62
5yr Average Asset Turnover Ratio	0.6	0.9	0.47
5yr Avg Net Profit Margin	12.9 %	14.56 %	24.38 %
Price to Book	3.29	3.02	11.18
P/E	22.84	23.09	23.28
5yr Avg Cash Conversion Cycle	-51.45 Days	71.65 Days	4.83 Days
Inventory Days	69.05 Days	89.77 Days	66.8 Days
Days Receivable	60.35 Days	65.99 Days	31.98 Days
Days Payable	225.58 Days	88.81 Days	63.37 Days
5yr Average Interest Coverage Ratio	0.72	38.03	906.11
5yr Avg ROCE	10.5 %	21.95 %	27.19 %
5yr Avg Operating Profit Margin	12.17 %	20.32 %	24.71 %
5 yr average Debt to Equity	1.01	0.02	0.0
5yr CAGR Net Profit	68.01 %	10.03 %	31.63 %
5yr Average Return on Assets	10.97 %	13.19 %	11.5 %
Shareholdings
Promoter Holding	27.86 %	43.87 %	60.4 %
Share Pledged by Promoters	44.13 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-3.21 %	-4.73 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.16 %	2.97 %	0.97 %

Business

	Strides Pharma Scien	Marksans Pharma	Sanofi India
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Vitamins & Suppliments 0 Anti-Cancer 0 Anti-Hair Fall 0 Central Nervous System 0 Antibiotics 0 Anti-allergic 0 Miscellaneous 0 Gastro-intestinal 0 Anti-diabetic 0 Cough and colds 0 Cardiovascular system (CVS) 0 Pain management 0 Pharmaceuticals 0	Product Wise Break-Up Cardiac Science 9.2 Vitamins & Suppliments 0 Antibiotics 0 Central Nervous System (CNS) 8.1 Miscellaneous 0 Pain Management 44.0 Anti - Diabetes 1.6 Cough and colds 14.0 Anti-Cancer 0 Anti-allergic 0 Pharmaceutical 0 Gastro Intestinal 8.5 Anti-Hair Fall 0 Pharmaceuticals 0 Others 14.6	Product Wise Break-Up Cardiovascular system (CVS) 0 Vitamins & Suppliments 0 Antibiotics 0 Central Nervous System 0 Miscellaneous 0 Pain management 0 Anti-diabetic 0 Cough and colds 0 Anti-Cancer 0 Anti-allergic 0 Pharmaceutical 0 Gastro-intestinal 0 Anti-Hair Fall 0 Pharmaceutical 100.0
Location Wise Break-Up	Location Wise Break-Up North America 53.68 Europe 21.77 Africa 10.11 Australia 9.63 Asia Pacific 0.49 India 0.35 Singapore 0 Others 3.97	Location Wise Break-Up India 0 Asia Pacific 0 Australia 8.5 Africa 0 Europe 34.1 Singapore 0 North America 53.8 Others 3.6	Location Wise Break-Up India 79.71 Asia Pacific 0 Australia 0 Africa 0 Europe 0 Singapore 20.29 North America 0
Operating Profit Break-Up	Operating Profit Break-Up Pharmaceutical 100.0	-	-
Customer Segment	Customer Segment Regulated market 83.0 Emerging Market 11.0 Institutional Business 0 OTC 0 Rx 0 Others 6.0	Customer Segment Rx 21.2 OTC 78.8 Emerging Market 0 Regulated market 0 Institutional Business 0	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise India 43.68 Asia ex India 22.48 North America 18.17 Europe 10.2 Africa 5.48 Australia 0	-	-
Asset Break-Up	Asset Break-Up Pharmaceutical 97.35 Bio-Pharmaceutical 2.65	-	-

Strides Pharma Science Ltd.

Strides Pharma Science Ltd.

Financial

Business

SIGN UP FOR FREE